(Q34646570)
Statements
1 reference
Superior long-term outcome with idarubicin compared with high-dose daunorubicin in patients with acute myeloid leukemia age 50 years and older (English)
1 reference
Sylvie Chevret
1 reference
Pierre Fenaux
1 reference
Hervé Dombret
1 reference
Emmanuel Raffoux
1 reference
Pascal Turlure
1 reference
Cécile Pautas
1 reference
Thierry de Revel
1 reference
Aline Renneville
1 reference
Nicolas Boissel
1 reference
Christine Terré
1 reference
Karine Celli-Lebras
1 reference
Sylvie Castaigne
1 reference
Dominique Bordessoule
1 reference
Claude Gardin
1 reference
Xavier Thomas
1 reference
17 December 2012
1 reference
1 reference
Identifiers
1 reference